查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
罕见血液学的全球市场，2024-2028
市场调查报告书
商品编码
1581056

罕见血液学的全球市场，2024-2028

Global Rare Hematology Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 210 Pages | 订单完成后即时交付

价格

稀有血液学市场，2024-2028

2023-2028 年，罕见血液学市场价值估计为 45.851 亿美元，预测期内复合年增长率为 5.7%。该报告包括对罕见血液学市场的总体分析、市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的驱动因素包括战略投资组合的强化、对罕见血癌基因突变的日益关注以及罕见血液疾病的流行。

市场范围
基准年 2024年
结束年份 2028年
预测期 2024-2028
成长动力 加速度
年与前一年同期比较[2024] 5.1%
复合年增长率 5.7%
增量 45.851 亿美元

该研究将食品药物管理局(FDA) 的核准视为未来几年推动罕见血液学市场成长的关键原因之一。此外，越来越多地采用现代化临床试验方法和扩大行业合作也将导致市场的强劲需求。

目录

第一章执行摘要

  • 市场概况

第二章 Technavio 分析

  • 价格、生命週期、顾客购买篮、采用率与购买标准分析
  • 输入的重要性和差异化因素
  • 令人困惑的因素
  • 驱动因素和挑战的影响

第三章 市场状况

  • 市场生态系统
  • 市场特征
  • 价值链分析

第四章市场规模评估

  • 市场定义
  • 细分市场分析
  • 2023 年市场规模
  • 2023-2028年市场展望

第五章 市场规模表现

  • 罕见血液学的全球市场 2018-2022
  • 2018-2022 年按疾病类型細項分析
  • 2018-2022 年最终用户細項分析
  • 2018-2022 年区域細項分析
  • 2018-2022 年国家細項分析

第6章定性分析

  • 人工智慧 (AI) 对全球罕见血液学市场的影响

第7章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争威胁
  • 市场状况

第八章市场细分：依疾病类型

  • 市场区隔
  • 比较：依疾病类型
  • 血友病：2023-2028 年市场规模与预测
  • 镰状细胞疾病：2023-2028 年市场规模与预测
  • 地中海型贫血：2023-2028 年市场规模与预测
  • 骨髓发育不良症候群：2023-2028年市场规模与预测
  • 按疾病类型分類的市场机会

第 9 章 市场区隔：依最终用户

  • 市场区隔
  • 比较：按最终用户
  • 医院：2023-2028 年市场规模与预测
  • 专科诊所：2023-2028 年市场规模与预测
  • 研究院：2023-2028年市场规模及预测
  • 製药公司：2023-2028年市场规模及预测
  • 最终用户的市场机会

第十章 客户情况

  • 客户状况概览

第十一章 地区情势

  • 区域细分
  • 比较：按地区
  • 北美：2023-2028 年市场规模与预测
  • 欧洲：2023-2028 年市场规模与预测
  • 亚洲：2023-2028 年市场规模与预测
  • 其他：2023-2028年市场规模与预测
  • 美国：2023-2028 年市场规模与预测
  • 中国：2023-2028年市场规模及预测
  • 英国：2023-2028 年市场规模与预测
  • 德国：2023-2028年市场规模与预测
  • 日本：2023-2028年市场规模与预测
  • 印度：2023-2028年市场规模与预测
  • 法国：2023-2028年市场规模与预测
  • 义大利：2023-2028年市场规模与预测
  • 韩国：2023-2028年市场规模及预测
  • 新加坡：2023-2028 年市场规模与预测
  • 按区域情况分類的市场机会

第十二章 促进因素、挑战、机会与限制因素

  • 市场驱动因素
  • 市场问题
  • 驱动因素和挑战的影响
  • 市场机会与限制

第十三章竞争格局

  • 概述
  • 竞争格局
  • 混乱的情况
  • 产业风险

第14章竞争分析

  • 公司简介
  • 公司排名指数
  • 公司市场定位
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • bluebird bio Inc.
  • Bristol Myers Squibb Co.
  • CSL Ltd.
  • F. Hoffmann La Roche Ltd.
  • Jazz Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.

第十五章附录

Product Code: IRTNTR80228

Rare Hematology Market 2024-2028

The rare hematology market is forecasted to grow by USD 4585.1 million during 2023-2028, accelerating at a CAGR of 5.7% during the forecast period. The report on the rare hematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by enhancement of strategic portfolios, growing focus on genetic variants in rare blood cancers, and prevalence of rare hematologic disorders.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.1%
CAGR5.7%
Incremental Value$4585.1 mn

Technavio's rare hematology market is segmented as below:

By Disease Type

    • Hemophilia
    • Sickle cell disease
    • Thalassemia
    • Myelodysplastic syndromes

By End-user

    • Hospitals
    • Specialty clinics
    • Research institutes
    • Pharmaceutical companies

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the approvals from food and drug administration (FDA) as one of the prime reasons driving the rare hematology market growth during the next few years. Also, increasing adoption of modernized clinical trial methods and expansion of industry collaborations will lead to sizable demand in the market.

The report on the rare hematology market covers the following areas:

    • Rare Hematology Market sizing
    • Rare Hematology Market forecast
    • Rare Hematology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rare hematology market vendors that include AbbVie Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., CSL Ltd., Emmaus Medical Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Grifols SA, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Octapharma AG, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the rare hematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Disease Type
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Rare Hematology Market 2018 - 2022
    • Historic Market Size - Data Table on Global Rare Hematology Market 2018 - 2022 ($ million)
  • 5.2 Disease Type segment analysis 2018 - 2022
    • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
  • 5.3 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 5.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 5.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of Artificial Intelligence (AI) in the global rare hematology market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Disease Type

  • 8.1 Market segments
    • Chart on Disease Type - Market share 2023-2028 (%)
    • Data Table on Disease Type - Market share 2023-2028 (%)
  • 8.2 Comparison by Disease Type
    • Chart on Comparison by Disease Type
    • Data Table on Comparison by Disease Type
  • 8.3 Hemophilia - Market size and forecast 2023-2028
    • Chart on Hemophilia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hemophilia - Market size and forecast 2023-2028 ($ million)
    • Chart on Hemophilia - Year-over-year growth 2023-2028 (%)
    • Data Table on Hemophilia - Year-over-year growth 2023-2028 (%)
  • 8.4 Sickle cell disease - Market size and forecast 2023-2028
    • Chart on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
    • Data Table on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
    • Chart on Sickle cell disease - Year-over-year growth 2023-2028 (%)
    • Data Table on Sickle cell disease - Year-over-year growth 2023-2028 (%)
  • 8.5 Thalassemia - Market size and forecast 2023-2028
    • Chart on Thalassemia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Thalassemia - Market size and forecast 2023-2028 ($ million)
    • Chart on Thalassemia - Year-over-year growth 2023-2028 (%)
    • Data Table on Thalassemia - Year-over-year growth 2023-2028 (%)
  • 8.6 Myelodysplastic syndromes - Market size and forecast 2023-2028
    • Chart on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
    • Data Table on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
    • Chart on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
    • Data Table on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
  • 8.7 Market opportunity by Disease Type
    • Market opportunity by Disease Type ($ million)
    • Data Table on Market opportunity by Disease Type ($ million)

9 Market Segmentation by End-user

  • 9.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 9.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 9.3 Hospitals - Market size and forecast 2023-2028
    • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 9.4 Specialty clinics - Market size and forecast 2023-2028
    • Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
    • Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
    • Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • 9.5 Research institutes - Market size and forecast 2023-2028
    • Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
    • Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
    • Chart on Research institutes - Year-over-year growth 2023-2028 (%)
    • Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
  • 9.6 Pharmaceutical companies - Market size and forecast 2023-2028
    • Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
    • Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 9.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 11.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 11.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 11.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 11.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 11.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 11.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 11.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 11.12 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ million)
    • Data Table on India - Market size and forecast 2023-2028 ($ million)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 11.13 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 11.14 Italy - Market size and forecast 2023-2028
    • Chart on Italy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Italy - Market size and forecast 2023-2028 ($ million)
    • Chart on Italy - Year-over-year growth 2023-2028 (%)
    • Data Table on Italy - Year-over-year growth 2023-2028 (%)
  • 11.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 11.16 Singapore - Market size and forecast 2023-2028
    • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
    • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
    • Chart on Singapore - Year-over-year growth 2023-2028 (%)
    • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
  • 11.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 14.5 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 14.6 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 14.7 bluebird bio Inc.
    • bluebird bio Inc. - Overview
    • bluebird bio Inc. - Product / Service
    • bluebird bio Inc. - Key offerings
    • SWOT
  • 14.8 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
    • SWOT
  • 14.9 CSL Ltd.
    • CSL Ltd. - Overview
    • CSL Ltd. - Business segments
    • CSL Ltd. - Key news
    • CSL Ltd. - Key offerings
    • CSL Ltd. - Segment focus
    • SWOT
  • 14.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 14.11 Jazz Pharmaceuticals Plc
    • Jazz Pharmaceuticals Plc - Overview
    • Jazz Pharmaceuticals Plc - Product / Service
    • Jazz Pharmaceuticals Plc - Key news
    • Jazz Pharmaceuticals Plc - Key offerings
    • SWOT
  • 14.12 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 14.13 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 14.14 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 14.15 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
    • SWOT
  • 14.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 14.17 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 14.18 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
    • SWOT

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits11: Overview on criticality of inputs and factors of differentiation
  • Exhibits12: Overview on factors of disruption
  • Exhibits13: Impact of drivers and challenges in 2023 and 2028
  • Exhibits14: Parent Market
  • Exhibits15: Data Table on - Parent Market
  • Exhibits16: Market characteristics analysis
  • Exhibits17: Value Chain Analysis
  • Exhibits18: Offerings of companies included in the market definition
  • Exhibits19: Market segments
  • Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits24: Historic Market Size - Data Table on Global Rare Hematology Market 2018 - 2022 ($ million)
  • Exhibits25: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
  • Exhibits26: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits29: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits35: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits36: Chart on Disease Type - Market share 2023-2028 (%)
  • Exhibits37: Data Table on Disease Type - Market share 2023-2028 (%)
  • Exhibits38: Chart on Comparison by Disease Type
  • Exhibits39: Data Table on Comparison by Disease Type
  • Exhibits40: Chart on Hemophilia - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Hemophilia - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Hemophilia - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Hemophilia - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Sickle cell disease - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Sickle cell disease - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Thalassemia - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Thalassemia - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Thalassemia - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Thalassemia - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Disease Type ($ million)
  • Exhibits57: Data Table on Market opportunity by Disease Type ($ million)
  • Exhibits58: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits59: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits60: Chart on Comparison by End-user
  • Exhibits61: Data Table on Comparison by End-user
  • Exhibits62: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Market opportunity by End-user ($ million)
  • Exhibits79: Data Table on Market opportunity by End-user ($ million)
  • Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits83: Chart on Geographic comparison
  • Exhibits84: Data Table on Geographic comparison
  • Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits118: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits119: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits122: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits123: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits124: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits125: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits126: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits127: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits128: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits129: Chart on Italy - Market size and forecast 2023-2028 ($ million)
  • Exhibits130: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
  • Exhibits131: Chart on Italy - Year-over-year growth 2023-2028 (%)
  • Exhibits132: Data Table on Italy - Year-over-year growth 2023-2028 (%)
  • Exhibits133: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits134: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits135: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits136: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits137: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Exhibits138: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Exhibits139: Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Exhibits140: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
  • Exhibits141: Market opportunity By Geographical Landscape ($ million)
  • Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits143: Impact of drivers and challenges in 2023 and 2028
  • Exhibits144: Overview on criticality of inputs and factors of differentiation
  • Exhibits145: Overview on factors of disruption
  • Exhibits146: Impact of key risks on business
  • Exhibits147: Companies covered
  • Exhibits148: Company ranking index
  • Exhibits149: Matrix on companies position and classification
  • Exhibits150: AbbVie Inc. - Overview
  • Exhibits151: AbbVie Inc. - Product / Service
  • Exhibits152: AbbVie Inc. - Key news
  • Exhibits153: AbbVie Inc. - Key offerings
  • Exhibits154: SWOT
  • Exhibits155: AstraZeneca Plc - Overview
  • Exhibits156: AstraZeneca Plc - Product / Service
  • Exhibits157: AstraZeneca Plc - Key news
  • Exhibits158: AstraZeneca Plc - Key offerings
  • Exhibits159: SWOT
  • Exhibits160: Bayer AG - Overview
  • Exhibits161: Bayer AG - Business segments
  • Exhibits162: Bayer AG - Key news
  • Exhibits163: Bayer AG - Key offerings
  • Exhibits164: Bayer AG - Segment focus
  • Exhibits165: SWOT
  • Exhibits166: bluebird bio Inc. - Overview
  • Exhibits167: bluebird bio Inc. - Product / Service
  • Exhibits168: bluebird bio Inc. - Key offerings
  • Exhibits169: SWOT
  • Exhibits170: Bristol Myers Squibb Co. - Overview
  • Exhibits171: Bristol Myers Squibb Co. - Product / Service
  • Exhibits172: Bristol Myers Squibb Co. - Key news
  • Exhibits173: Bristol Myers Squibb Co. - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: CSL Ltd. - Overview
  • Exhibits176: CSL Ltd. - Business segments
  • Exhibits177: CSL Ltd. - Key news
  • Exhibits178: CSL Ltd. - Key offerings
  • Exhibits179: CSL Ltd. - Segment focus
  • Exhibits180: SWOT
  • Exhibits181: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits182: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits183: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits184: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits185: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits186: SWOT
  • Exhibits187: Jazz Pharmaceuticals Plc - Overview
  • Exhibits188: Jazz Pharmaceuticals Plc - Product / Service
  • Exhibits189: Jazz Pharmaceuticals Plc - Key news
  • Exhibits190: Jazz Pharmaceuticals Plc - Key offerings
  • Exhibits191: SWOT
  • Exhibits192: Johnson and Johnson Services Inc. - Overview
  • Exhibits193: Johnson and Johnson Services Inc. - Business segments
  • Exhibits194: Johnson and Johnson Services Inc. - Key news
  • Exhibits195: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits196: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits197: SWOT
  • Exhibits198: Merck and Co. Inc. - Overview
  • Exhibits199: Merck and Co. Inc. - Business segments
  • Exhibits200: Merck and Co. Inc. - Key news
  • Exhibits201: Merck and Co. Inc. - Key offerings
  • Exhibits202: Merck and Co. Inc. - Segment focus
  • Exhibits203: SWOT
  • Exhibits204: Novartis AG - Overview
  • Exhibits205: Novartis AG - Business segments
  • Exhibits206: Novartis AG - Key news
  • Exhibits207: Novartis AG - Key offerings
  • Exhibits208: Novartis AG - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: Novo Nordisk AS - Overview
  • Exhibits211: Novo Nordisk AS - Business segments
  • Exhibits212: Novo Nordisk AS - Key offerings
  • Exhibits213: Novo Nordisk AS - Segment focus
  • Exhibits214: SWOT
  • Exhibits215: Pfizer Inc. - Overview
  • Exhibits216: Pfizer Inc. - Product / Service
  • Exhibits217: Pfizer Inc. - Key news
  • Exhibits218: Pfizer Inc. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: Sanofi SA - Overview
  • Exhibits221: Sanofi SA - Business segments
  • Exhibits222: Sanofi SA - Key news
  • Exhibits223: Sanofi SA - Key offerings
  • Exhibits224: Sanofi SA - Segment focus
  • Exhibits225: SWOT
  • Exhibits226: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits227: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits229: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits230: SWOT
  • Exhibits231: Inclusions checklist
  • Exhibits232: Exclusions checklist
  • Exhibits233: Currency conversion rates for US$
  • Exhibits234: Research methodology
  • Exhibits235: Information sources
  • Exhibits236: Data validation
  • Exhibits237: Validation techniques employed for market sizing
  • Exhibits238: Data synthesis
  • Exhibits239: 360 degree market analysis
  • Exhibits240: List of abbreviations